⌘K

Login Start Free

Home/Filings/4/0001483813-13-000101

4//SEC Filing

HALOZYME THERAPEUTICS INC 4

Accession 0001483813-13-000101

$HALOCIK 0001159036operating

View on SEC.gov Company Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 7:33 PM ET

Size

13.3 KB

Accession

0001483813-13-000101

Insider Transaction Report

Form 4

Period: 2013-12-11

HALOZYME THERAPEUTICS INCHALO

Frost Gregory Ian

DirectorVP and Chief Scientific Off.

Transactions

Exercise/Conversion
Common Stock
2013-12-11$2.02/sh+6,467$13,063→ 3,608,267 total
Exercise/Conversion
Option to Purchase Common Stock (ISO)
2013-12-11−6,467→ 0 total
Exercise: $2.02From: 2004-12-08Exp: 2014-12-08→ Common Stock (6,467 underlying)
Exercise/Conversion
Option to Purchase Common Stock (NSO)
2013-12-11−10,420→ 34,864 total
Exercise: $2.02From: 2004-12-08Exp: 2014-12-08→ Common Stock (10,420 underlying)
Exercise/Conversion
Common Stock
2013-12-11$2.02/sh+10,420$21,048→ 3,601,800 total
Exercise/Conversion
Common Stock
2013-12-11$2.05/sh+33,113$67,882→ 3,641,380 total
Exercise/Conversion
Option to Purchase Common Stock (ISO)
2013-12-11−33,113→ 667 total
Exercise: $2.05From: 2008-02-02Exp: 2014-10-13→ Common Stock (33,113 underlying)

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001159036

Filing Metadata

Form type: 4
Filed: Dec 10, 7:00 PM ET
Accepted: Dec 11, 7:33 PM ET
Size: 13.3 KB

View on SEC.gov